This video was published 168 Days 23 Hours 1 Min ago.
Premium Access: Available NOW Member Access: Available NOW Public Access: Available NOW
THE 3 MINUTE PRESS SHOW with Tracee Tolentino
Discover the News behind the News from today's leading executives. Each day we interview the leading Executives on the press of that day.
The 3 Minute Press Show gives you the:
Who, What, Where, When, Why and How of this Press and how it will impact the company and its shareholders.
Members are encouraged to ask these executives questions through their message boards at Mywallst
Opexa Therapeutics develops and commercializes cell therapies to treat autoimmune diseases such as MS, rheumatoid arthritis, and diabetes. The Company is focused on autologous cellular therapy applications of its proprietary T-cell and stem cell therapies. The Company's lead product, Tovaxin, a T-cell therapy for multiple sclerosis is in Phase IIb trials. The Company holds the exclusive worldwide license for adult multipotent stem cells derived from mononuclear cells of peripheral blood. The technology allows large quantities of monocyte derived stem cells to be produced efficiently for use in autologous therapy, thus circumventing the threat of rejection. The Company is in preclinical development for diabetes mellitus. For more information, visit the Opexa Therapeutics website at www.opexatherapeutics.com.
Last Trade
0.19
Volume
78,100
Change
+0.04
Shares
n.a.
Change %
+26.75%
Market Cap.
1.84M
Today's High
0.20
52 Week High
n.a.
Today's Low
0.13
52 Week Low
n.a.
Bid
0.04 x n.a.
EPS
-1.56
Ask
0.20 x n.a.
P/E Ratio
-0.09615
Open
0.20
Div. Per Share
n.a.
Previous Close
0.15
Exchange
NMS
User Comments
0 Bulls
0 Bears
Be the first to comment on Opexa Therapeutics, Inc (NASDAQ: OPXA)
GeneThera, Inc., a development stage biotechnology company, develops molecular assays for the detection of food contaminating pathogens, veterinary diseases, and genetically modified organisms. The co...
Avasant is recognized as one of the "Top-Ten" strategic sourcing advisory
firms by the Black Book of Outsourcing. Avasant helps clients navigate the
complete lifecycle for sourcing IT, Business and...
Featured Company:
